Drug
Mogamulizumab KW 0761
Mogamulizumab KW 0761: highest development phase Phase 1, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mogamulizumab: KW-0761, Nivolumab: (ONO-4538/BMS-936558) NCT02476123 | Phase 1 | Solid Tumor |
Latest
No recent events.
Follow Mogamulizumab KW 0761 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.